Abstract
DS22: The impact of using teledermatology versus face‐to‐face reviews when seeing patients that are referred via the 2‐week wait pathway for suspected cancers, and overcoming some of the barriers in the new <scp>COVID</scp> era
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have